Primary immunodeficiency syndrome and Poor venous access

Summary:

Poor venous access is found among people with Primary immunodeficiency syndrome, especially for people who are female, 60+ old.

The study analyzes which people have Poor venous access with Primary immunodeficiency syndrome. It is created by eHealthMe based on reports of 285 people who have Primary immunodeficiency syndrome from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Primary immunodeficiency syndrome?

Primary immunodeficiency syndrome is found to be associated with 6 drugs and 49 conditions by eHealthMe. Check the latest studies of Primary immunodeficiency syndrome.

What is Poor venous access?

Poor venous access is found to be associated with 674 drugs and 480 conditions by eHealthMe. Check the latest studies of Poor venous access.

On Jul, 21, 2026

285 people who have Primary Immunodeficiency Syndrome and Poor Venous Access are studied.

Would you have Poor venous access when you have Primary immunodeficiency syndrome?

Gender of people who have Primary immunodeficiency syndrome and experienced Poor venous access *:

Click here to view

Age of people who have Primary immunodeficiency syndrome and experienced Poor venous access *:

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Poor venous access?

- Check whether Poor venous access is associated with a drug or a condition

Related studies:

Treatments, associated drugs and conditions:

Primary immunodeficiency syndrome (12,159 reports)
Poor venous access (14,290 reports)

All the drugs that are associated with Poor venous access:

Poor venous access (674 drugs)

All the conditions that are associated with Poor venous access:

Poor venous access (480 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Poor venous access and Primary immunodeficiency syndrome, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.